{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:22:05Z","timestamp":1769833325106,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["17\/0005627"],"award-info":[{"award-number":["17\/0005627"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["ETM\/47"],"award-info":[{"award-number":["ETM\/47"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00125-019-4900-7","type":"journal-article","created":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T04:09:57Z","timestamp":1558238997000},"page":"1375-1384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Glycaemic control trends in people with type 1 diabetes in Scotland 2004\u20132016"],"prefix":"10.1007","volume":"62","author":[{"name":"on behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group","sequence":"first","affiliation":[]},{"given":"Colette","family":"Mair","sequence":"first","affiliation":[]},{"given":"Wahyu","family":"Wulaningsih","sequence":"additional","affiliation":[]},{"given":"Anita","family":"Jeyam","sequence":"additional","affiliation":[]},{"given":"Stuart","family":"McGurnaghan","sequence":"additional","affiliation":[]},{"given":"Luke","family":"Blackbourn","sequence":"additional","affiliation":[]},{"given":"Brian","family":"Kennon","sequence":"additional","affiliation":[]},{"given":"Graham","family":"Leese","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Lindsay","sequence":"additional","affiliation":[]},{"given":"Rory J.","family":"McCrimmon","sequence":"additional","affiliation":[]},{"given":"John","family":"McKnight","sequence":"additional","affiliation":[]},{"given":"John R.","family":"Petrie","sequence":"additional","affiliation":[]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[]},{"given":"Sarah H.","family":"Wild","sequence":"additional","affiliation":[]},{"given":"Nicholas","family":"Conway","sequence":"additional","affiliation":[]},{"given":"Ian","family":"Craigie","sequence":"additional","affiliation":[]},{"given":"Kenneth","family":"Robertson","sequence":"additional","affiliation":[]},{"given":"Louise","family":"Bath","sequence":"additional","affiliation":[]},{"given":"Paul M.","family":"McKeigue","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8345-3288","authenticated-orcid":false,"given":"Helen M.","family":"Colhoun","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,5,18]]},"reference":[{"issue":"1","key":"4900_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2014.16425","volume":"313","author":"SJ Livingstone","year":"2015","unstructured":"Livingstone SJ, Levin D, Looker HC et al (2015) Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA 313(1):37\u201344. \n                    https:\/\/doi.org\/10.1001\/jama.2014.16425","journal-title":"JAMA"},{"issue":"10","key":"4900_CR2","doi-asserted-by":"publisher","first-page":"e1001321","DOI":"10.1371\/journal.pmed.1001321","volume":"9","author":"SJ Livingstone","year":"2012","unstructured":"Livingstone SJ, Looker HC, Hothersall EJ et al (2012) Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 9(10):e1001321. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1001321","journal-title":"PLoS Med"},{"issue":"1","key":"4900_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/jama.2014.16107","volume":"313","author":"TJ Orchard","year":"2015","unstructured":"Orchard TJ, Nathan DM, Zinman B et al (2015) Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA 313(1):45. \n                    https:\/\/doi.org\/10.1001\/jama.2014.16107","journal-title":"JAMA"},{"issue":"8","key":"4900_CR4","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/dme.12676","volume":"32","author":"JA McKnight","year":"2015","unstructured":"McKnight JA, Wild SH, Lamb MJE et al (2015) Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med 32(8):1036\u20131050. \n                    https:\/\/doi.org\/10.1111\/dme.12676","journal-title":"Diabet Med"},{"key":"4900_CR5","unstructured":"Director-General Health & Social Care and Chief Executive NHS Scotland (2012) Insulin pump therapy for people with type 1 diabetes. \n                    https:\/\/www.sehd.scot.nhs.uk\/mels\/cel2012_04.pdf\n                    \n                  . Accessed November 2018"},{"key":"4900_CR6","unstructured":"Scottish Diabetes Survey Monitoring Group (2016) Scottish Diabetes Survey 2016. \n                    http:\/\/www.diabetesinscotland.org.uk\/Publications\/Scottish%20Diabetes%20Survey%202016.pdf\n                    \n                  . Accessed November 2018"},{"issue":"9","key":"4900_CR7","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1007\/s00125-012-2601-6","volume":"55","author":"L Govan","year":"2012","unstructured":"Govan L, Maietti E, Torsney B et al (2012) The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia 55(9):2356\u20132360. \n                    https:\/\/doi.org\/10.1007\/s00125-012-2601-6","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"4900_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc18-Sint01","volume":"41","author":"H Bakst","year":"2018","unstructured":"Bakst H (2018) Introduction: Standards of Medical Care in Diabetes\u20142018. Diabetes Care 41(Suppl 1):S1\u2013S2. \n                    https:\/\/doi.org\/10.2337\/dc18-Sint01","journal-title":"Diabetes Care"},{"key":"4900_CR9","unstructured":"National Institute for Health and Care Excellence (2008) Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. \n                    https:\/\/www.nice.org.uk\/guidance\/ta151\n                    \n                  . Accessed November 2018"},{"issue":"7","key":"4900_CR10","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1177\/0962280216673085","volume":"27","author":"DS Nagin","year":"2018","unstructured":"Nagin DS, Jones BL, Passos VL, Tremblay RE (2018) Group-based multi-trajectory modeling. Stat Methods Med Res 27(7):2015\u20132023. \n                    https:\/\/doi.org\/10.1177\/0962280216673085","journal-title":"Stat Methods Med Res"},{"key":"4900_CR11","doi-asserted-by":"publisher","DOI":"10.1201\/9781315370279","volume-title":"Generalized additive models: an introduction with R","author":"SN Wood","year":"2017","unstructured":"Wood SN (2017) Generalized additive models: an introduction with R, 2nd edn. Chapman and Hall\/CRC, USA. \n                    https:\/\/doi.org\/10.1201\/9781315370279","edition":"2nd"},{"issue":"2","key":"4900_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pcd.2009.05.004","volume":"3","author":"A Gikas","year":"2009","unstructured":"Gikas A, Sotiropoulos A, Pastromas V, Papazafiropoulou A, Apostolou O, Pappas S (2009) Seasonal variation in fasting glucose and HbA1c in patients with type 2 diabetes. Prim Care Diabetes 3(2):111\u2013114. \n                    https:\/\/doi.org\/10.1016\/j.pcd.2009.05.004","journal-title":"Prim Care Diabetes"},{"key":"4900_CR13","unstructured":"Simpson G (2014) Identifying periods of change in time series with GAMs. \n                    https:\/\/www.fromthebottomoftheheap.net\/2014\/05\/15\/identifying-periods-of-change-with-gams\/\n                    \n                  . Accessed November 2018"},{"issue":"2","key":"4900_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2337\/db18-0515","volume":"68","author":"RG Miller","year":"2019","unstructured":"Miller RG, Costacou T, Orchard TJ (2019) Risk factor modeling for cardiovascular disease in type 1 diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: a comparison to the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study. Diabetes 68(2):409\u2013419. \n                    https:\/\/doi.org\/10.2337\/db18-0515","journal-title":"Diabetes"},{"issue":"42","key":"4900_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22420","volume":"22","author":"J Blair","year":"2018","unstructured":"Blair J, McKay A, Ridyard C et al (2018) Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT. Health Technol Assess 22(42):1\u2013112. \n                    https:\/\/doi.org\/10.3310\/hta22420","journal-title":"Health Technol Assess"},{"issue":"1","key":"4900_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/dme.13786","volume":"36","author":"TC Evans-Cheung","year":"2019","unstructured":"Evans-Cheung TC, Campbell F, Yong J, Parslow RC, Feltbower RG (2019) HbA1c values and hospital admissions in children and adolescents receiving continuous subcutaneous insulin infusion therapy. Diabet Med 36(1):88\u201395. \n                    https:\/\/doi.org\/10.1111\/dme.13786","journal-title":"Diabet Med"},{"issue":"3","key":"4900_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.15277\/bjdvd.2015.033","volume":"15","author":"JA McKnight","year":"2015","unstructured":"McKnight JA (2015) The Scottish Diabetes Improvement Plan 2014. Br J Diabetes 15(3):131. \n                    https:\/\/doi.org\/10.15277\/bjdvd.2015.033","journal-title":"Br J Diabetes"},{"issue":"4","key":"4900_CR18","doi-asserted-by":"publisher","first-page":"e016766","DOI":"10.1136\/bmjopen-2017-016766","volume":"8","author":"DJ Pollard","year":"2018","unstructured":"Pollard DJ, Brennan A, Dixon S et al (2018) Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial. BMJ Open 8(4):e016766. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2017-016766","journal-title":"BMJ Open"},{"key":"4900_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.diabres.2016.03.008","volume":"115","author":"B Bohn","year":"2016","unstructured":"Bohn B, Kerner W, Seufert J et al (2016) Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: analysis of real-life data from the DPV registry from Germany and Austria. Diabetes Res Clin Pract 115:31\u201338. \n                    https:\/\/doi.org\/10.1016\/j.diabres.2016.03.008","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"4900_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/1932296818785622","volume":"12","author":"G Nordin","year":"2018","unstructured":"Nordin G (2018) Accuracy of HbA1c as monitored by external quality assessment and compared with patient mean values. J Diabetes Sci Technol 12(4):771\u2013779. \n                    https:\/\/doi.org\/10.1177\/1932296818785622","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"4900_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2337\/dc15-0078","volume":"38","author":"KM Miller","year":"2015","unstructured":"Miller KM, Foster NC, Beck RW et al (2015) Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic Registry. Diabetes Care 38(6):971\u2013978. \n                    https:\/\/doi.org\/10.2337\/dc15-0078","journal-title":"Diabetes Care"},{"issue":"4","key":"4900_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s13300-017-0280-5","volume":"8","author":"G Carls","year":"2017","unstructured":"Carls G, Huynh J, Tuttle E, Yee J, Edelman SV (2017) Achievement of glycated hemoglobin goals in the US remains unchanged through 2014. Diabetes Ther 8(4):863\u2013873. \n                    https:\/\/doi.org\/10.1007\/s13300-017-0280-5","journal-title":"Diabetes Ther"},{"issue":"12","key":"4900_CR23","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2337\/dc16-2680","volume":"40","author":"VW Zhong","year":"2017","unstructured":"Zhong VW, Juhaeri J, Cole SR et al (2017) Incidence and trends in hypoglycemia hospitalization in adults with type 1 and type 2 diabetes in England, 1998\u20132013: a retrospective cohort study. Diabetes Care 40(12):1651\u20131660. \n                    https:\/\/doi.org\/10.2337\/dc16-2680","journal-title":"Diabetes Care"},{"key":"4900_CR24","unstructured":"NHS Digital (2018) National Diabetes Audit. \n                    https:\/\/digital.nhs.uk\/data-and-information\/clinical-audits-and-registries\/national-diabetes-audit\n                    \n                  . Accessed November 2018"},{"issue":"6","key":"4900_CR25","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.2337\/dc17-2271","volume":"41","author":"D Charalampopoulos","year":"2018","unstructured":"Charalampopoulos D, Hermann JM, Svensson J et al (2018) Exploring variation in glycemic control across and within eight high-income countries: a cross-sectional analysis of 64,666 children and adolescents with type 1 diabetes. Diabetes Care 41(6):1180\u20131187. \n                    https:\/\/doi.org\/10.2337\/dc17-2271","journal-title":"Diabetes Care"},{"key":"4900_CR26","unstructured":"NHS Scotland (2009) HbA1c standardisation for laboratory professionals. \n                    http:\/\/www.diabetesinscotland.org.uk\/Publications\/HbA1c_Lab_leaflet_0509.pdf\n                    \n                  . Accessed November 2018"},{"issue":"8","key":"4900_CR27","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","unstructured":"The Diabetes Control and Complications Trial Research Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44(8):968\u2013983. \n                    https:\/\/doi.org\/10.2337\/diab.44.8.968","journal-title":"Diabetes"},{"key":"4900_CR28","doi-asserted-by":"publisher","unstructured":"Akbar T, McGurnaghan S, Palmer CNA et al (2016) Cohort profile: Scottish Diabetes Research Network Type 1 Bioresource Study (SDRNT1BIO). Int J Epidemiol 46(3):796\u2013769i. \n                    https:\/\/doi.org\/10.1093\/ije\/dyw152","DOI":"10.1093\/ije\/dyw152"},{"issue":"1","key":"4900_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/dme.13519","volume":"35","author":"LME Lindner","year":"2018","unstructured":"Lindner LME, Rathmann W, Rosenbauer J (2018) Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio-economic status and area-level deprivation in type 1 diabetes mellitus: a systematic review. Diabet Med 35(1):12\u201332. \n                    https:\/\/doi.org\/10.1111\/dme.13519","journal-title":"Diabet Med"},{"issue":"4","key":"4900_CR30","doi-asserted-by":"publisher","first-page":"e007290","DOI":"10.1136\/bmjopen-2014-007290","volume":"5","author":"L Low","year":"2015","unstructured":"Low L, Law JP, Hodson J, McAlpine R, O\u2019Colmain U, MacEwen C (2015) Impact of socioeconomic deprivation on the development of diabetic retinopathy: a population-based, cross-sectional and longitudinal study over 12 years. BMJ Open 5(4):e007290. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2014-007290","journal-title":"BMJ Open"},{"issue":"4","key":"4900_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/apa.12530","volume":"103","author":"L Hanberger","year":"2014","unstructured":"Hanberger L, \u00c5kesson K, Samuelsson U (2014) Glycated haemoglobin variations in paediatric type 1 diabetes: the impact of season, gender and age. Acta Paediatr 103(4):398\u2013403. \n                    https:\/\/doi.org\/10.1111\/apa.12530","journal-title":"Acta Paediatr"},{"issue":"1","key":"4900_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3343\/alm.2012.32.1.17","volume":"32","author":"N Sinha","year":"2012","unstructured":"Sinha N, Mishra TK, Singh T, Gupta N (2012) Effect of iron deficiency anemia on hemoglobin A1c levels. Ann Lab Med 32(1):17. \n                    https:\/\/doi.org\/10.3343\/alm.2012.32.1.17","journal-title":"Ann Lab Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-4900-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:31:42Z","timestamp":1589671902000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-4900-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,18]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4900"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-4900-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,18]]},"assertion":[{"value":"18 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HMC has received grants, personal fees and non-financial support from Eli Lilly & Company, grants from Pfizer Inc., grants from Boehringer Ingelheim, grants from AstraZeneca LP, grants, personal fees and non-financial support from Sanofi, non-financial support from Novartis Pharmaceuticals and personal fees and non-financial support from Regeneron. HMC received grants from and holds shares at Roche Pharmaceuticals, is a shareholder in Bayer and has received non-financial support from Sanofi Aventis outside the submitted work. All other authors declare that there is no duality of interested associated with their contribution to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}